Sr. Director - Digital Transformation Tax/Treasury at Eli Lilly and Company

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, PharmaceuticalsIndustries

Requirements

Inquisitive about technology and energized by transformation
Ready to champion change across systems, data, and processes
Ability to partner with leaders and external experts to define and execute digital strategy
Knowledge of emerging technologies (e.g., AI/ML, APIs, blockchain, intelligent automation, data lakes, RPA, workflow engines, Power BI, Alteryx)
Experience in technology leadership, including owning roadmaps for upgrades, automation, and process redesign in cash management, payments, FX, investments, debt, tax provision, and tax return processes
Ability to serve as a liaison with technology teams (e.g., Tech@Lilly, Advanced Analytics, Data Sciences Architecture)
Comprehensive understanding of emerging technology trends and their impact on tax and treasury operations
Skills in identifying and redesigning legacy processes for automation and real-time data integration
Experience in process transformation, intelligent reconciliation, analytics dashboards, and promoting innovation/continuous improvement
Strong collaboration skills with stakeholders in finance, tax, risk management, treasury operations, banks, fintech vendors, and solution providers
Expertise in change management, adoption, and training

Responsibilities

Help define and drive the modernization of global tax and treasury functions
Act as a bridge to technology, leading the design and execution of tax and treasury’s digital transformation agenda (process automation, real-time visibility, AI-driven forecasting, intelligent workflows)
Support diverse finance areas including global/federal/state tax, global treasury, pension/benefits management, insurance/risk management, and business development financial support
Partner with leaders and external experts to define and execute a forward-looking digital strategy aligned with finance transformation goals
Continuously evaluate and pilot emerging technologies to enhance agility, accuracy, and value
Lead contributions to enterprise initiatives (e.g., digital cash flow forecasting, FX management, virtual account structures, bank connectivity modernization, AI-based risk modeling, valuation modeling/benchmarking, data/market analysis, R&D credit analysis, US tax return enhancements, quarterly/year-end close modernization, legal entity forecast/accounting tax processes, transfer pricing automation, indirect tax automations)
Evaluate next-generation tools to accelerate tax and treasury reporting/operational requirements
Own the roadmap for upgrades, automation, and process redesign across cash management, payments, FX, investments, debt, tax provision, and tax return for global direct tax/transfer pricing
Serve as key liaison with Tech@Lilly, Advanced Analytics, and Data Sciences Architecture teams to prioritize and support needs
Develop and maintain understanding of emerging technology trends impacting tax/treasury operations
Identify and redesign legacy processes using RPA, workflow engines, Power BI, Alteryx; drive real-time data integration, intelligent reconciliation, and analytics dashboards
Promote a culture of innovation and continuous improvement; implement best practices for process optimization/automation to enhance efficiency and reduce risk
Partner with stakeholders in finance, tax, risk management, and treasury to align digital goals with business priorities
Build external relationships with banks, fintech vendors, and solution providers
Lead change management efforts to drive adoption and training

Skills

APIs

Blockchain

Intelligent Automation

Data Lakes

Process Automation

Digital Transformation

Tax

Treasury

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free